Tonix Pharmaceuticals (TNXP) Q1 2025 Earnings

18MarConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-388
-259.76
-131.52
-3.27

Details

Expected EPS
-18.5
Actual EPS
-9.77
Surprise EPS
8.73
Surprise Percent
+47.19%

Description

Tonix Pharmaceuticals (TNXP) has reported earnings of -9.77 per share for Q1 2025.

0 Comments

Share your thoughts